Antibodies which bind B7RP1
    1.
    发明授权
    Antibodies which bind B7RP1 有权
    结合B7RP1的抗体

    公开(公告)号:US07435796B1

    公开(公告)日:2008-10-14

    申请号:US09890729

    申请日:2000-01-27

    摘要: Novel polypeptides which comprise a receptor-ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding said polypeptides, and vectors and host cells for expressing same are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders.

    摘要翻译: 公开了包含参与T细胞活化的受体 - 配体对的新型多肽。 还公开了编码所述多肽的核酸分子,以及用于表达其的载体和宿主细胞。 多肽或其激动剂和拮抗剂用于治疗T细胞介导的病症。

    Downregulation of immune response by administering B7RP-2 fusion protein
    5.
    发明授权
    Downregulation of immune response by administering B7RP-2 fusion protein 有权
    通过施用B7RP-2融合蛋白降低免疫反应

    公开(公告)号:US07482325B2

    公开(公告)日:2009-01-27

    申请号:US11229307

    申请日:2005-09-16

    CPC分类号: C07K14/70532

    摘要: The present invention provides B7 Related Protein-2 (B7RP-2) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7RP-2 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7RP-2 polypeptides.

    摘要翻译: 本发明提供B7相关蛋白-2(B7RP-2)多肽和编码该多肽的核酸分子。 本发明还提供选择性结合剂,载体,宿主细胞和用于产生B7RP-2多肽的方法。 本发明进一步提供用于诊断,治疗,改善和/或预防与B7RP-2多肽相关的疾病,病症和病症的药物组合物和方法。

    B7RP-1 antagonists
    8.
    发明授权
    B7RP-1 antagonists 有权
    B7RP-1拮抗剂

    公开(公告)号:US08470317B2

    公开(公告)日:2013-06-25

    申请号:US12286099

    申请日:2008-09-25

    IPC分类号: A61K39/395

    摘要: Novel polypeptides which comprise a receptor-ligand pair involved in T-cell, activation are disclosed. Nucleic acid molecules encoding said polypeptides, and vectors and host cells for expressing same are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders.

    摘要翻译: 公开了包含参与T细胞活化的受体 - 配体对的新型多肽。 还公开了编码所述多肽的核酸分子,以及用于表达其的载体和宿主细胞。 多肽或其激动剂和拮抗剂用于治疗T细胞介导的病症。